Atlas Trials

Study of Gemcitabine and Cisplatin With or Without Cetuximab in Urothelial Cancer

Clinical trial NCT00645593 · COMPLETED

Trial details

NCT number
NCT00645593
Sponsor
University of Michigan Rogel Cancer Center
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Bladder Cancer
Start date
2008-03-01
Primary completion
2014-04-01
Enrollment
89

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.